Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
NCT Number: NCT06303687
This study aims to use functional near-infrared spectroscopy (fNIRS) to identify and quantify pain biomarkers during burn dressing changes and pain relief induced by virtual reality (VR).
Trial opening soon.
Get Notified6 year–17 year
All sexes
Interventional
Not applicable
Columbus, Ohio, 43205, United States
The objective of this study is to develop central nervous system (CNS) biomarkers of pain experience during inpatient pediatric (age 6-17 years) burn dressing changes and pain relief induced by virtual reality (VR). We plan to use innovative functional near-infrared spectroscopy (fNIRS) to identify and quantify the targeted CNS biomarkers. The ultimate goal of this project is to optimize the CNS biomarkers for predicting and/or monitoring response to VR-based pain reduction approaches for pain management in clinical trials.
We will collaborate through a team science model to recruit n=4 pediatric burn injury subjects to address the following three specific aims:
Aim 1: To quantify the central nervous system (CNS) responses associated with self-reported pain intensity during a standard clinical procedure (burn dressing changes).
Aim 2: To assess brain response patterns to virtual reality (VR)-based interventions for pain management.
Aim 3: To assess the degree to which objective brain measures and brain responses to VR intervention modulate objective brain markers of pain.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Virtual Reality Pain Alleviation Therapy (VR-PAT) played on a Pico Neo 3 Pro Eye device
Other names: Virtual Reality
Time frame: Assessed continuously throughout burn dressing changes (60 minutes) for the fNIRS study period (up to 5 days)
Mean change of hemoglobin oxygen (HBO2) concentration between VR and Control as detected by fNIRS.
Time frame: Assessed within 15 minutes immediately after the burn dressing change about pain experienced during the procedure
0-10 Numerical Rating Scale (NRS) (self-reported and caregiver-reported), 0(min)-10(max), with higher score indicating worse pain. Asked for worst pain, average pain, and time spent thinking about pain. Collected in both VR and Control group.
Time frame: Assessed at 3 time points (30 minutes prior to procedure, immediately prior to procedure, and within 15 minutes immediately following the procedure) for each dressing change
Modified Yale Preoperative Anxiety Scale (mYPAS) (observed by researcher), 23.33(min)-100(max), with higher scores denoting higher levels of anxiety.
Time frame: Within 15 minutes immediately following burn dressing change when in VR-PAT group
0-10 Numerical Rating Scale (NRS) (self-reported - VR-PAT arm only), 0(min)-10(max), with higher score meaning better outcome. Asked for degree of realism, pleasure, and satisfaction with VR.
Contact information is provided by the study sponsor or research team.
Nationwide Children's Hospital
Other
Imaging Pain in a Virtual World: Neuroimaging Biomarkers for Assessing Brain Mechanisms Mediating Virtual Reality Pain Management in Children
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05673551
Acute Pain, Burns
Columbus, Ohio, United States
View Trial DetailsNCT04548635
Acute Pain, Burns
Columbus, Ohio, United States
View Trial DetailsNCT06795126
Acute Pain, Anxiety Disorders
Columbus, Ohio, United States
View Trial DetailsNCT05073497
Acute Pain, Agnosia
Istanbul, Kartal, Turkey (Türkiye)
View Trial Details